AR co-activators such as SRC-1, SRC-3, TIF-2 [53], [54] which could enhance the transcriptional activity of AR and contribute to the sensitization of AR to low levels of androgen concentrations are also elevated in prostate cancer. Here, AR is linked to Familial prostate cancer.